Curative raised over $150 million in series B funding, bringing its valuation to $1.275 billion, according to a Dec. 2 news release.
The startup, formerly a COVID-19 testing company, offers health insurance plans with no out-of-pocket costs — as long as members attend an annual preventive health visit — in Texas, Florida and Georgia.
The capital infusion will help the insurer scale across the country, first focusing on Mid-Atlantic states. Curative also plans to invest in member engagement, AI-enhanced capabilities and network development.
“The healthcare industry is notoriously challenging with so many misaligned incentives. To see Curative successfully setting a new standard for employer-based health insurance that actually makes people healthier — wow, that has been exhilarating,” said Chris Anderson, managing partner at Upside Vision Fund, who led the latest funding round.
Curative serves over 1,200 employer clients and 165,000 members.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.